PainQx is currently advancing our novel AI-powered objective pain assessment technology through on-going R&D activities in preparation for an FDA validation study in 2020. To support our efforts, PainQx is seeking to build relationships with partners that share our vision for improving chronic pain management. Our goal is to collaborate with investors, clinicians, chronic pain patients, drug-development companies, and technology suppliers that can help support our mission. If you are interested in learning more about our work and how you might be able to contribute, please contact us at [email protected] for more information.
PainQx is proud to have been supported by a number of Investors in our Seed and Bridge Round.
With their support, PainQx has been actively developing our novel technology – thank you.